KNSA
Kiniksa Pharmaceuticals Ltd
75.70$
-0.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 49.4% | 23.6% | 10.4% | 20.9% | 14.4% | 45.4% | |
| – | – | – | – | -49.4% | 76.4% | 89.6% | 79.1% | 85.6% | 54.6% | |
| – | – | – | – | 1,454.3% | 257.6% | 29.7% | 28.2% | 26.4% | 14.3% | |
| – | – | – | – | 588.3% | 223.0% | 44.5% | 44.4% | 37.0% | 29.0% | |
| – | – | – | – | 2,042.6% | 482.8% | 85.2% | 88.4% | 96.4% | 43.2% | |
| – | – | – | – | -2,042.6% | -406.4% | 4.4% | -9.3% | -10.8% | 11.4% | |
| – | – | – | – | 45.9% | 6.4% | 0.6% | – | – | – | |
| – | – | – | – | -2,027.9% | -406.1% | 5.0% | -6.2% | -8.5% | 13.1% | |
| – | – | – | – | 66.9% | 3.6% | -78.3% | -11.4% | 1.7% | 4.4% | |
| – | – | – | – | -2,094.8% | -409.7% | 83.3% | 5.2% | -10.2% | 8.7% | |
| – | – | – | – | -2,011.4% | -400.3% | 6.1% | -5.3% | -8.1% | 13.3% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.